Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 71

1.

Morphological features of iPS cells generated from Fabry disease skin fibroblasts using Sendai virus vector (SeVdp).

Kawagoe S, Higuchi T, Otaka M, Shimada Y, Kobayashi H, Ida H, Ohashi T, Okano HJ, Nakanishi M, Eto Y.

Mol Genet Metab. 2013 Aug;109(4):386-9. doi: 10.1016/j.ymgme.2013.06.003. Epub 2013 Jun 12.

PMID:
23810832
2.

Development of defective and persistent Sendai virus vector: a unique gene delivery/expression system ideal for cell reprogramming.

Nishimura K, Sano M, Ohtaka M, Furuta B, Umemura Y, Nakajima Y, Ikehara Y, Kobayashi T, Segawa H, Takayasu S, Sato H, Motomura K, Uchida E, Kanayasu-Toyoda T, Asashima M, Nakauchi H, Yamaguchi T, Nakanishi M.

J Biol Chem. 2011 Feb 11;286(6):4760-71. doi: 10.1074/jbc.M110.183780. Epub 2010 Dec 7.

3.

Neural differentiation of patient specific iPS cells as a novel approach to study the pathophysiology of multiple sclerosis.

Song B, Sun G, Herszfeld D, Sylvain A, Campanale NV, Hirst CE, Caine S, Parkington HC, Tonta MA, Coleman HA, Short M, Ricardo SD, Reubinoff B, Bernard CC.

Stem Cell Res. 2012 Mar;8(2):259-73. doi: 10.1016/j.scr.2011.12.001. Epub 2011 Dec 13.

4.

Adenoviral gene delivery can reprogram human fibroblasts to induced pluripotent stem cells.

Zhou W, Freed CR.

Stem Cells. 2009 Nov;27(11):2667-74. doi: 10.1002/stem.201.

5.

Efficient generation of rat induced pluripotent stem cells using a non-viral inducible vector.

Merkl C, Saalfrank A, Riesen N, Kühn R, Pertek A, Eser S, Hardt MS, Kind A, Saur D, Wurst W, Iglesias A, Schnieke A.

PLoS One. 2013;8(1):e55170. doi: 10.1371/journal.pone.0055170. Epub 2013 Jan 31.

6.

New type of Sendai virus vector provides transgene-free iPS cells derived from chimpanzee blood.

Fujie Y, Fusaki N, Katayama T, Hamasaki M, Soejima Y, Soga M, Ban H, Hasegawa M, Yamashita S, Kimura S, Suzuki S, Matsuzawa T, Akari H, Era T.

PLoS One. 2014 Dec 5;9(12):e113052. doi: 10.1371/journal.pone.0113052. eCollection 2014.

7.

Generation of human iPS cell line CTL07-II from human fibroblasts, under defined and xeno-free conditions.

Kele M, Day K, Rönnholm H, Schuster J, Dahl N, Falk A.

Stem Cell Res. 2016 Nov;17(3):474-478. doi: 10.1016/j.scr.2016.09.028. Epub 2016 Sep 30.

8.

Generation of induced pluripotent stem cells by reprogramming human fibroblasts with the stemgent human TF lentivirus set.

Wu D, Hamilton B, Martin C, Gao Y, Ye M, Yao S.

J Vis Exp. 2009 Dec 8;(34). pii: 1553. doi: 10.3791/1553.

9.

Novel Strategy to Control Transgene Expression Mediated by a Sendai Virus-Based Vector Using a Nonstructural C Protein and Endogenous MicroRNAs.

Sano M, Iijima M, Ohtaka M, Nakanishi M.

PLoS One. 2016 Oct 20;11(10):e0164720. doi: 10.1371/journal.pone.0164720. eCollection 2016.

10.

Direct reprogramming of rat neural precursor cells and fibroblasts into pluripotent stem cells.

Chang MY, Kim D, Kim CH, Kang HC, Yang E, Moon JI, Ko S, Park J, Park KS, Lee KA, Hwang DY, Chung Y, Lanza R, Kim KS.

PLoS One. 2010 Mar 24;5(3):e9838. doi: 10.1371/journal.pone.0009838.

11.

Polycistronic lentiviral vector for "hit and run" reprogramming of adult skin fibroblasts to induced pluripotent stem cells.

Chang CW, Lai YS, Pawlik KM, Liu K, Sun CW, Li C, Schoeb TR, Townes TM.

Stem Cells. 2009 May;27(5):1042-9. doi: 10.1002/stem.39.

12.

Generation of human induced pluripotent stem cells from cord blood cells.

Nishishita N, Takenaka C, Fusaki N, Kawamata S.

J Stem Cells. 2011;6(3):101-8.

PMID:
23264996
13.

Integration-free induced pluripotent stem cells derived from retinitis pigmentosa patient for disease modeling.

Jin ZB, Okamoto S, Xiang P, Takahashi M.

Stem Cells Transl Med. 2012 Jun;1(6):503-9. doi: 10.5966/sctm.2012-0005. Epub 2012 Jun 1.

14.
15.

Gingival fibroblasts as a promising source of induced pluripotent stem cells.

Egusa H, Okita K, Kayashima H, Yu G, Fukuyasu S, Saeki M, Matsumoto T, Yamanaka S, Yatani H.

PLoS One. 2010 Sep 14;5(9):e12743. doi: 10.1371/journal.pone.0012743.

16.

Potential application of induced pluripotent stem cells in cell replacement therapy for Parkinson's disease.

Chen LW, Kuang F, Wei LC, Ding YX, Yung KK, Chan YS.

CNS Neurol Disord Drug Targets. 2011 Jun;10(4):449-58. Review.

PMID:
21495962
17.

Generation of induced pluripotent stem (iPS) cells derived from a murine model of Pompe disease and differentiation of Pompe-iPS cells into skeletal muscle cells.

Kawagoe S, Higuchi T, Meng XL, Shimada Y, Shimizu H, Hirayama R, Fukuda T, Chang H, Nakahata T, Fukada S, Ida H, Kobayashi H, Ohashi T, Eto Y.

Mol Genet Metab. 2011 Sep-Oct;104(1-2):123-8. doi: 10.1016/j.ymgme.2011.05.020. Epub 2011 Jun 2.

PMID:
21703893
18.

Generation of mouse induced pluripotent stem cells from different genetic backgrounds using Sleeping beauty transposon mediated gene transfer.

Muenthaisong S, Ujhelly O, Polgar Z, Varga E, Ivics Z, Pirity MK, Dinnyes A.

Exp Cell Res. 2012 Nov 15;318(19):2482-9. doi: 10.1016/j.yexcr.2012.07.014. Epub 2012 Jul 28.

PMID:
22846649
19.

Induced pluripotent stem cells derived from mouse models of lysosomal storage disorders.

Meng XL, Shen JS, Kawagoe S, Ohashi T, Brady RO, Eto Y.

Proc Natl Acad Sci U S A. 2010 Apr 27;107(17):7886-91. doi: 10.1073/pnas.1002758107. Epub 2010 Apr 12.

20.

Characterization of Human Dermal Fibroblasts in Fabry Disease.

Lakomá J, Donadio V, Liguori R, Caprini M.

J Cell Physiol. 2016 Jan;231(1):192-203. doi: 10.1002/jcp.25072.

PMID:
26058984

Supplemental Content

Support Center